Skip to content
Search AI Powered

Latest Stories

Assisted Dying: RPS Scotland supports pharmacists' right to opt-out of the process

Assisted Dying: RPS Scotland supports pharmacists' right to opt-out of the process

RPS says that the ability of pharmacists to conscientiously object to Assisted Dying is essential

The Royal Pharmaceutical Society (RPS) has taken a neutral stance on the Assisted Dying for Terminally Ill Adults (Scotland) Bill but underscores that pharmacists should have the right to refuse involvement in the process.


The Bill, introduced to the Scottish Parliament by Liam McArthur MSP as a Private Members Bill, could make Scotland the first UK nation with assisted dying legislation if it passes into law.

This week, the RPS in Scotland released its consultation response to the Scottish Parliament’s Health, Social Care, and Sport Committee regarding the Bill, and made it clear that “the ability of pharmacists to conscientiously object to assisted dying is essential.”

The Society emphasised that “all pharmacists should have the right to take part, or not take part in the process, depending on their individual religious, moral or ethical beliefs.”

In its response, the RPS has also advocated for the inclusion of an opt-in section within the Bill.

“Pharmacists should only be taking part in this process, whether directly or indirectly, where they are comfortable to do so,” it said, noting that “this would not only support individual healthcare professionals but would also ensure the best patient care and experience.”

Furthermore, the RPS has called for greater clarity in the proposed role of the pharmacist in the assisted dying process.

“In the Bill as drafted, a pharmacist may be present in some circumstances but not in others.  There should be clarity and consistency throughout the process,” the Society noted.

As the draft Bill progresses through scrutiny by the Health, Social Care and Sport Committee and the legislative process, the RPS Scotland plans to continue presenting its views to MSPs and stakeholders throughout the country.

More For You

New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
It is official: Opella is now a standalone company

Opella launches as an independent company to redefine the future of self-care.

Photo credit: gettyimages

Opella becomes standalone company as Sanofi-CD&R deal closes

Opella has officially become a standalone company, following the completion of Sanofi’s sale of a controlling 50.0% stake to private equity firm Clayton, Dubilier & Rice (CD&R).

Sanofi retains a significant shareholding with a 48.2% stake while Bpifrance holds the remaining 1.8% stake.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less